July 28, 2020
Strongbridge Biopharma plc to Host Second Quarter 2020 Financial Results Conference Call on August 4, 2020
Media
July 27, 2020
Vicore Pharma doses first COVID-19 patient in the ATTRACT study in India
July 27, 2020
CARISMA Therapeutics Announces FDA Clearance of IND Application for First-Ever Engineered Macrophage Immunotherapy
July 22, 2020
GenSight Biologics reports final REALITY natural history study results confirming poor spontaneous recovery for LHON patients with ND4 mutation
July 17, 2020
Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)
July 17, 2020
Orexo Interim Report Q2 2020
July 17, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q2 2020 Interim report
July 10, 2020
BONESUPPORT HOLDING AB (publ) – Interim Report Q2 2020 – invitation to conference call and webcast
July 10, 2020
GenSight Biologics obtains a €7m non-dilutive loan and renegotiates the bond agreement with Kreos Capital extending runway to mid-2021
July 07, 2020
GenSight Biologics reports sustained efficacy and safety among LHON patients three years after LUMEVOQ® treatment
